Against this background, the use of multiple doses, principally double, continues. The purpose of this audit was to:-

Similar documents
REGIONAL AUDIT OF PLASMA PRODUCTS 2016

Looking after a Finite Resource. Adrian Ebbs Transfusion Laboratory Manager Queen Elizabeth Hospital King s Lynn

Home truths... the clinical use of components in the UK. Jonathan Wallis. Platelets, FFP, Cryoprecipitate

MANAGEMENT OF MASSIVE TRANSFUSION

ThromboLUX for determining platelet quality

Robert Elshaw Transfusion Manager Hull and East Yorkshire Hospitals NHS Trust

Consulted With; Post/Committee/Group Date Haematology Dr Shereen Elshazly (Lead for Anticoagulation) January 2016 Department of Anaesthesia

Hospital Experience. Mike Herbert - Transfusion Laboratory Manager New Cross Hospital Wolverhampton

Blood transfusion in special situations and poly-trauma. Dr Marina Karakantza Consultant Haematologist in Transfusion Medicine, LTHT

TAYSIDE GUIDE TO MASSIVE TRANSFUSION/BLOOD LOSS

Massive Haemorrhage J Davies B Ferguson

HRA/Ethics Approval for Health-Related Research

Therapeutic Apheresis Services. Annual Review 2015/16

iccnet CHSA Clinical Protocol - HEPARIN

Key changes in new BCSH Transfusion I.T. Guidelines. Debbie Asher EPA Network Transfusion Manager Member, BCSH Guideline Writing Group

The Birmingham Institute of Translational Medicine. Professor Charles Craddock

CURRENT PRACTICE IN HOSPITALS

Controlled Document Number: Version Number: 2 Controlled Document Sponsor: Controlled Document Lead:

Massive Haemorrhage P Donnelly B Ferguson

Cryoprecipitate audit within six centres in New Zealand.

CHANGE IN PLATELET USAGE

COMMISSIONING IMMUNOGLOBULIN

See Important Reminder at the end of this policy for important regulatory and legal information.

The Electronic Dispatch Note. Sue Rudd Blood Transfusion St Helier Hospital May 2010

Significant Improvement In The Management Of Major Obstetric Haemorrhage With A Rotem Guided Algorithm Using Fibrinogen Concentrate

JOB DESCRIPTION CPG BUSINESS PARTNER (8C) Band 8C - 51,471-68,379 (inclusive of London weighting)

TRANSLATIONAL RESEARCH PARTNERSHIPS

Manejo de la transfusión de plaquetas. Ileana López-Plaza, MD

Perioperative management of patients on warfarin requiring elective surgery Dr K Boyd, Mrs S Doyle

Lancashire Procurement Cluster November 2017

Clinical Commissioning Policy: Eculizumab for the treatment of refractory antibody mediated rejection post kidney transplant

Immunoglobulin Database Report 2015/16

NIHR TRANSLATIONAL RESEARCH COLLABORATION INFLAMMATORY RESPIRATORY DISEASE

Investigation of Severe Febrile Non-haemolytic Transfusion Reactions. Executive Summary Page 1. Introduction and Background Page 2

Managing platelet refractory patients: case studies. Presented by Paul F. Lindholm, M.D.

4/22/2015. Platelet antibody screen and crossmatch. HLA antibody testing methods. Matched platelet timeline. Lymphocytotoxicity. Luminex technology

HAEMOVIGILANCE. Ms. Emma O Riordan.

Annual Report 2016/17

Logan Construction.

January (San Francisco, CA) January 8, 2018

Improved analysis of genetic testing could lead to more patients with inherited conditions being successfully diagnosed

CORD BLOOD MEETING THE UNMET DEMAND

CHARING CROSS HAMMERSMITH QUEEN CHARLOTTE S & CHELSEA ST MARY S WESTERN EYE

TRANSFUSION MANAGEMENT OF MASSIVE HAEMORRHAGE

PLATELET GUIDANCE DOCUMENT

Version Number: 004. On: June 2018 Review Date: June 2021 Distribution: Essential Reading for: Information for: Page 1 of 10

Therapeutic monoclonal antibodies & blood transfusion Essential information for hospital transfusion laboratories, transfusion practitioners &

Prior Authorization Criteria Hemophilia/Blood Factor Products

Malcolm Robinson Chief BMS, WSHT, and Chair of SE Thames TA(D)G

DRUG NAME : Clexane (enoxaparin) Pre-Filled Syringes

Why one size does NOT fit all. Presentation by: Nicola Main Date: 24 September 2013

Organisational Learning Policy

Could you help lead the NHS in your area?

Legislation on NHS Consultation and Patient Involvement. Alistair Mills Landmark Chambers

MSc in Transfusion and Transplantation Sciences

CANCER CENTER SCIENTIFIC REVIEW COMMITTEE

GUARDIAN OF SAFE WORKING HOURS ANNUAL REPORT 2016/17 ON ROTA GAPS AND VACANCIES: DOCTORS AND DENTISTS IN TRAINING

New Model for Immunoglobulin Assessment Panels Implementation Pack

Details: Approval: Distribution & Storage:

The Strategy, Process and Application of Clinical Audit in the London Ambulance Service

External Audit: Annual Audit Letter

Job Description. Reporting to: Clinically: Consultant Haematologist Managerially: Director of Quality and Laboratory Operations Managers

PARTICIPANTS MANUAL. Point of Care RhD typing. UK NEQAS for Blood Transfusion Laboratory Practice

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health and Social Care Directorate. Indicator Process Guide. Published December 2017

argatroban, 100mg/ml, concentrate for solution for infusion (Exembol) SMC No. (812/12) Mitsubishi Pharma Europe Ltd

Document Title: Site Recruitment and Initiation for Papworth Sponsored Studies

DELIVERING EXCEPTIONAL FM IN HEALTHCARE GLOBAL WORKPLACE SOLUTIONS CBRE

NORTH WEST LONDON CCGS

August 2017 Newsletter Contents

Guidance on the appointment of consultant clinical scientists in pathology to employing bodies in the UK

Document Title: Annual Progress Reports (APRs) Document Number: 056

Annual Report UK NATIONAL EXTERNAL QUALITY ASSESSMENT SCHEME for Feto-Maternal Haemorrhage. UK NEQAS (FMH) PO Box 1000 Watford WD18 0WP

iwave awarded NHS Supply Contract for Modular Mobile Regeneration Systems

Leading for Cultures of Compassion and Inclusiveness in the NHS

A UK single-centre survey of red cell antibodies in adult patients undergoing liver transplantation

Title Agreed Surgical Blood Ordering Schedule Author Mrs. M. A. Webb. Author s job title Blood Transfusion Laboratory Manager Directorate Planned Care

What could be better than a blood bank full of blood? Ways to reduce wastage. Mark Yazer, MD University of Pittsburgh University of Southern Denmark

Board of Directors Meeting

Life Blood. Issue 22. Index. t: medical website clinical guidelines products & services. Dear Life Blood Reader <---

Laboratory Stewardship - The Power of Appropriate Test Utilization

Louise Brook Clinical Trials Quality Monitor. Date

DOCUMENT CONTROL PAGE

BAXTER HEALTHCARE v JOHNSON & JOHNSON WOUND MANAGEMENT

Comparison of admission rates to neonatal units between PO screening and non-po screening Units

NPIMR. Progress for Patients.

COMPARISON OF PLATELET COUNTS BY SYSMEX XE 2100 AND LH 750 WITH THE INTERNATIONAL FLOW REFERENCE METHOD IN THROMBOCYTOPENIC PATIENTS

Controlled Document Number: Version Number: 7 Controlled Document Sponsor: Controlled Document Lead:

Quick Guide to Specialty Recruitment Clare Wright National Specialty Recruitment Manager

Board of Directors Audit Committee

BIOMEDICAL RESEARCH CENTRES

CROSS HAMMERSMITH QUEEN CHARLOTTE S & CHELSEA ST MARY S WESTERN EYE

Customer Service Excellence - Telephone Monitoring Audit including Face to Face Contact Between Staff and Customers (TELMON1718)

Demand Management Plan for Immunoglobulin Use

Haematology Subcommittee of PTAC Meeting held 1 October (minutes for web publishing)

Type of intervention Secondary prevention. Economic study type Cost-effectiveness analysis.

Page 1 of 7. Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc)

BLOOD TRANSFUSION PETER HUDSON CLINICAL SPECIALIST

BLOOD TRANSFUSION PETER HUDSON CLINICAL SPECIALIST

Estimation of Feto-Maternal Haemorrhage

The Safe Carriage of Red Blood Cells in Aeromedical Retrievals

Transcription:

London Regional Transfusion Committee Audit of Multiple Dose Platelet Transfusion Requests across the London Regional Transfusion Committee region during a one week period in December 2014. Rachel Moss, Transfusion Practitioner, Imperial College Healthcare NHS Trust, Chair London Platelet Action Group (LoPAG) Clare Denison, Patient Blood Management Practitioner, NHSBT Megan Rowley, Consultant Haematologist, NHSBT and Imperial College Healthcare NHS Trust Brian Hockley, Data Analyst and Audit Manager, NHSBT Background This audit has been conducted against a background of a rising demand for platelets seen nationally by NHSBT. Generally, a single unit or 1 adult therapeutic dose (ATD) typically gives an immediate rise in platelet count of 20-40 x10 9 /l in thrombocytopenic patients without platelet antibodies. (1) Against this background, the use of multiple doses, principally double, continues. The purpose of this audit was to:- Determine how common requests for multiple dose platelets are received in blood transfusion laboratories across the London Regional Transfusion Committee (RTC) region; Determine the reason for multiple dose platelet requests; Determine the clinical speciality requesting multiple dose platelet transfusions and Determine how often the request is modified following consultation with a haematologist. Determine how often the pre-transfusion platelet count is below the trigger level set by the National Blood Transfusion Committee (NBTC) for a particular indication code. The standard of measure was: The dose of platelets in adults should not exceed one unit (1 ATD). Methods All hospital laboratories within the London RTC region were invited to participate in this audit via their named London Platelet Action Group (LoPAG) Platelet Champion and to record all multiple dose platelet requests for a period of one week. The date and time of the request was also recorded. In addition, if such requests were referred to a haematologist for review (as per hospital policy) this and any amendment to the request was recorded. The reason for the transfusion was also recorded using the appropriate NBTC indication (P) code. Data was recorded on paper proformas (see Appendix 1) and returned to the NHSBT Data Analyst and RTC Audit Manager for collation and analysis using SNAP software.

Analysis Results have been analysed as follows: The number of multiple dose requests received during the audit period. The number of multiple dose requests where following the advice of a haematologist the request was amended. The same data by recorded clinical speciality. The number of requests recorded for each individual indication code along with the proportion of these requests that we outside of the transfusion trigger for that code. Results Data was received from 29/50 (58%) hospitals in the LoPAG group. 205 (3 nil return) separate multiple dose transfusion requests were received over the data collection period accounting for a total of 431 units. Table 1 indicates the hospital laboratories that returned data, the number of multiple dose platelet requests they received during the audit period, the number of units that these requests accounted for along with the total number of units fated as both transfused and wasted during the audit period. Graph 1 shows number of multipledose platelet requests per hospital incrementally. At least 1 multiple dose platelet request was received by 26/29 (90%) of hospitals who submitted data. 4/29 (14%) hospitals did not supply data for the total number of platelets fated as transfused during the audit period and 6/29 (21%) did not supply data for to the number of units fated as wasted during the audit period.

Table 1 Name of hospital No of multidose requests Total number of units requested for multidose requests Total number of transfused platelet units during audit week (including all requests) Royal National Orthopaedic 2 4 4 0 Total number of platelet units wasted during audit week St Marys 6 12 41 3 Lewisham 2 4 3 0 Queen Elizabeth Woolwich 5 10 23 1 BUPA Cromwell 8 20 No Information No Information Bart s Health 15 30 No Information No Information Royal Marsden (Sutton) 7 17 17 0 Royal Marsden (Chelsea) 2 6 6 0 St Georges Hospital 4 8 52 Princess Royal University Hospital 1 2 2 1 Charing Cross 3 6 6 4 Hammersmith 15 31 86 2 Harefield 8 16 16 0 West Middlesex 0 n/a No Information No Information Royal Brompton 12 23 No Information No Information HCA International & London 12 26 50 Bridge Hospital 1 Great Ormond Street 13 26 22 No Information St Helier 6 12 39 3 Kingston 1 2 1 Croydon University Hospital 1 2 12 2 Epsom 1 2 17 0 Chelsea and Westminster Hospital 8 16 8 0 0 No Information Queens Romford 8 16 50 1 Royal Free 11 28 81 2 Kings College Hospital 48 100 68 29 Barnet & Chase Farm 4 8 14 1 Central Middlesex 0 n/a 1 1 The London Clinic 2 4 30 0 Northwick Park 0 n/a 24 2

Graph 1 Advice of Haematologist Haematological advice was sought in 111/205 (54%) of cases. Of these 111 cases, 96 (86%) retained the originally requested multiple dose; it was reduced in 7 (6%) of cases cancelled in 3 (3%) of cases In 5 (5%) of the cases the outcome of haematological advice was not documented. Specialities Table 2 indicates the principle clinical specialities involved in requesting multiple dose platelets. These account for 83% (170/205) of the requests received during the audit period. Table 2 Clinical Speciality No of Cases Haematology 62 Cardiac 30 Liver 23 Oncology 19 ITU 10 Surgical 12 Theatres 8 A&E 6 Total 170

The clinical speciality of Haematology includes Haematology/Oncology and also Immunohaematological patients. Those cases involving cardiac and cardiac surgery requested haematological advice in 2/30 (7%) of cases. Table 3 indicates the NBTC Indication (P) codes and the number of cases receiving multiple doses that cited this as the indication. The table also indicates the percentage of these requests where the patients pre-transfusion platelet count was recorded as being above the trigger for that indication code and would therefore be considered as an inappropriate transfusion. 73 (36%) of the cases recorded during the audit did not have any indication code documented for the request. Table 3 P code Number of Platelet Count Trigger % Outside indication trigger requests P1 17 <10x10 9 /l 53% (9/17) P2 15 <20x10 9 /l 73% (11/15) P3 57 >50x10 9 /l 35% (20/57)* >80x10 9 /l (epidural) >100x10 9 /l (CNS/eye surgery) P4 8 >75x10 9 /l 50% (4/8)** >100x10 9 /l(multiple, CNS/eye trauma) P5 3 n/a n/a P6 5 n/a n/a P7 0 n/a n/a P8 0 >80x10 9 /l (Pre major n/a surgery) >70x10 9 /l (obstetric regional axia anaesthesia) P9 0 n/a n/a P10 15*** >30x10 9 /l 73% (11/15) Other 12 n/a n/a Not recorded 73 n/a n/a Total 205 *10 cases where pre-transfusion platelet count not recorded ** 1 case where pre-transfusion platelet count not recorded *** 15 cases provided by 1 Trust it is not clear if this indication code has been recorded in error.

Summary Discussion The audit has identified a large variation in the proportion of patients receiving multiple dose platelets between hospitals. However, some have probably not provided accurate information on the total number of platelets transfused over the period due to misinterpretation of what was required. Haematological advice was not sought in 46% of multiple dose platelet requests. Cardiac cases only sought advice in 2/30 (7%) of double dose requests. Many patients receive multiple dose platelet transfusions when their pretransfusion platelet counts were measured at or above the trigger thresholds for the indication codes recorded. The clinical specialities of haematology, cardiac, liver and oncology account for the majority (65%) of multiple dose requests recorded during the audit. The 2010 National Comparative Audit (NCA) of platelet transfusions in Haematology audited 3,296 platelet transfusions over a 3 month period and found that 10% were double dose requests. One of the key recommendations of this audit with regard to prophylactic platelet transfusions was that Double dose platelet transfusions should not be used routinely. When platelets are given prophylactically to adults, it is recommended that one adult therapeutic dose is given. This should increase the platelet count by at least 20x10 9 /l providing the patient is not refractory (i.e. has platelet antibodies). However, when platelets are given therapeutically to treat active bleeding, a larger dose of platelets may be indicated; the dose and frequency of administration depends on the individual circumstances, and it is not possible to give general advice. (2) This audit has identified the fact that despite previous national audits, guidelines and peer reviewed evidence the practice of giving multiple dose platelet transfusions to patients still occurs on a regular basis, often endorsed by haematologists. It may be a further audit covering a longer period would provide a more accurate picture of multiple dose platelet requests in the LoPAG region. Limitations The question asked in the summary of cases audited asking about the total number of platelets units issued and fated as transfused was poorly worded. As a result the denominator data could not be collected and used in the analysis. Recommendations 1. The RTC should run an audit on where do platelets go to evaluate where more focus of education and resources are required to support the reduction of double dose, inappropriate and wastage of platelets. 2. LoPAG to present this audit at the April 2015 RTC Meeting. 3. LoPAG to further discuss this audit at the next LoPAG champions day and consider other resources that can be developed to support a reduction in multi-doe requesting and challenging by haematologists.

References 1. Norfolk D (Ed) (2013) Handbook of Transfusion Medicine 5 th Edition, The Stationary Office. 2. Guidelines for the Use of Platelet Transfusions, British Journal of Haematology (2003); 122:10-23 3. Slichter SJ et al Dose of prophylactic platelet transfusions and prevention of haemorrhage, NEJM (2010); 362:600-13

APPENDIX 1 Audited Patient Number London RTC Double-Dose Platelet Audit Data Collection Log Name of Hospital Do not put unique patient identifiable information on this Audit Data Log The Audit Data Log should Number returned of to Reason NHSBT for for data Was entry the and request analysis Day Speciality Pre transfusion (multiple) transfusion referred to a Date & platelet count platelet units (indication haematologist? Time of request requested code) Y/N If Y, what was the outcome? Log Sheet No. (circle) 1 2 3 4 Comment (optional) 1 SAME/REDUCE/CANCEL 2 SAME/REDUCE/CANCEL 3 SAME/REDUCE/CANCEL 4 SAME/REDUCE/CANCEL 5 SAME/REDUCE/CANCEL 6 SAME/REDUCE/CANCEL 7 SAME/REDUCE/CANCEL 8 SAME/REDUCE/CANCEL